Log in to save to my catalogue

Isoflurane, like sepsis, decreases CYP1A2 liver enzyme activity in intensive care patients: a clinic...

Isoflurane, like sepsis, decreases CYP1A2 liver enzyme activity in intensive care patients: a clinic...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_698231156bee42bdb7c39f52720930b7

Isoflurane, like sepsis, decreases CYP1A2 liver enzyme activity in intensive care patients: a clinical study and network model

About this item

Full title

Isoflurane, like sepsis, decreases CYP1A2 liver enzyme activity in intensive care patients: a clinical study and network model

Publisher

Cham: Springer International Publishing

Journal title

Intensive Care Medicine Experimental, 2024-04, Vol.12 (1), p.33-33, Article 33

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Purpose
Liver function of intensive care patients is routinely monitored by static blood pathology. For specific indications, liver specific cytochrome activity may be measured by the commercially available maximum liver function capacity (LiMAx) test via quantification of the cytochrome P450 1A2 (CYP1A2) dependent C-methacetin metabolism. Sedat...

Alternative Titles

Full title

Isoflurane, like sepsis, decreases CYP1A2 liver enzyme activity in intensive care patients: a clinical study and network model

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_698231156bee42bdb7c39f52720930b7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_698231156bee42bdb7c39f52720930b7

Other Identifiers

ISSN

2197-425X

E-ISSN

2197-425X

DOI

10.1186/s40635-024-00617-8

How to access this item